Emcure Pharmaceuticals Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE168P01015 52Wk High (Rs.) 1580 BV (Rs.) 217.34 FV (Rs.) 10.00
Bookclosure 14/08/2025 52Wk Low (Rs.) 889 EPS (Rs.) 35.95 P/E (X) 37.61
Mkt Cap. (Rs. Cr.) 25,621.53 P/BV (X) 6.22 Div Yield (%) 0.22 Mkt Lot 1
 
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)16.958.898.8524.7123.25
Diluted EPS (Rs.)16.958.898.8524.7123.25
Cash EPS (Rs.)28.6120.1818.7233.8731.89
Book Value[Excl.RevalReserv]/Share (Rs.)159.61106.82101.8494.69127.27
Book Value[Incl.RevalReserv]/Share (Rs.)159.61106.82101.8494.69127.27
Dividend / Share (Rs.)3.003.002.001.001.00
Revenue From Operations / Share (Rs.)231.26193.08171.80187.29174.38
PBDIT / Share (Rs.)40.4132.0231.1851.2847.29
PBIT / Share (Rs.)28.5320.7221.3142.1138.65
PBT / Share (Rs.)22.5711.0411.7434.0830.82
Net Profit / Share (Rs.)16.748.888.8524.7023.25
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)17.4716.5818.1427.3727.12
PBIT Margin (%)12.3310.7312.4022.4822.16
PBT Margin (%)9.765.716.8318.1917.67
Net Profit Margin (%)7.234.595.1513.1913.33
Return on Networth / Equity (%)10.488.318.6926.0918.26
Return on Capital Employeed (%)14.6214.2814.7031.8722.74
Return On Assets (%)5.853.383.4610.338.64
Long Term Debt / Equity (X)0.130.220.320.290.28
Total Debt / Equity (X)0.210.730.900.910.56
Asset Turnover Ratio (%)0.860.740.690.730.72
      
LIQUIDITY RATIOS     
      
Current Ratio (X)1.430.991.071.101.24
Quick Ratio (X)0.820.630.710.720.89
Inventory Turnover Ratio (X)4.851.471.301.591.97
Dividend Payout Ratio (NP) (%)0.0033.7322.5912.144.30
Dividend Payout Ratio (CP) (%)0.0014.8310.688.853.13
Earning Retention Ratio (%)0.0066.2777.4187.8695.70
Cash Earning Retention Ratio (%)0.0085.1789.3291.1596.87
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)6.783.493.386.396.93
Interest Coverage Ratio (Post Tax) (%)3.812.022.004.084.56
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)20969.760.000.000.000.00
EV / Net Operating Revenue (X)4.790.000.000.000.00
EV / EBITDA (X)27.390.000.000.000.00
MarketCap / Net Operating Revenue (X)4.640.000.000.000.00
Retention Ratios (%)0.0066.2677.4087.8595.69
Price / BV (X)6.720.000.000.000.00
Price / Net Operating Revenue (X)4.640.000.000.000.00
EarningsYield0.010.000.000.000.00